Emerging Strategies in TCR-Engineered T Cells

Immunotherapy of cancer has made tremendous progress in recent years, as demonstrated by the remarkable clinical responses obtained from adoptive cell transfer (ACT) of patient-derived tumor infiltrating lymphocytes, chimeric antigen receptor (CAR)-modified T cells (CAR-T) and T cell receptor (TCR)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Fang, Cheng, Xiao-Xia, Xue, John Zhao, Xue, Shao-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006933/
https://www.ncbi.nlm.nih.gov/pubmed/35432319
http://dx.doi.org/10.3389/fimmu.2022.850358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006933/
https://www.ncbi.nlm.nih.gov/pubmed/35432319
http://dx.doi.org/10.3389/fimmu.2022.850358

Ejemplares similares